Effects of telmisartan and olmesartan on insulin sensitivity and renal function in spontaneously hypertensive rats fed a high fat diet.

作者: Hayato Yanagihara , Kentaro Ushijima , Yusuke Arakawa , Ken-ichi Aizawa , Akio Fujimura

DOI: 10.1016/J.JPHS.2016.06.003

关键词:

摘要: Although telmisartan, an angiotensin II receptor blocker (ARB), has agonistic action for proliferator-activated (PPAR)-γ in vitro, it remains to be determined whether telmisartan exerts such vivo using a non-toxic dose (<5 mg/kg rats). To address the issue, (2 mg/kg) and olmesartan mg/kg), another ARB without PPAR-γ action, were given spontaneously hypertensive rats (SHR) fed high fat diet (HFD). HFD decreased plasma adiponectin, caused insulin resistance, hypertriglyceridemia renal damage, which improved by ARBs. Protective effects of did not significantly differ. In addition, vitro study showed that 1 μM elevate mRNA expression adipose protein 2, is PPAR-γ-stimulated adipogenic marker gene, preadipocytes with 3% albumin. obtain concentration, oral was calculated 6 mg/kg, indicates negligible rats. This 2 ameliorated damage SHR HFD. As beneficial differ, these mediated through PPAR-γ-independent actions.

参考文章(23)
Hui Tang, Becky M. Sebastian, Armend Axhemi, Xiaocong Chen, Antoinette D. Hillian, Donald W. Jacobsen, Laura E. Nagy, Ethanol‐Induced Oxidative Stress via the CYP2E1 Pathway Disrupts Adiponectin Secretion from Adipocytes Alcoholism: Clinical and Experimental Research. ,vol. 36, pp. 214- 222 ,(2012) , 10.1111/J.1530-0277.2011.01607.X
T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, N. Tsuboyama-Kasaoka, O. Ezaki, Y. Akanuma, O. Gavrilova, C. Vinson, M.L. Reitman, H. Kagechika, K. Shudo, M. Yoda, Y. Nakano, K. Tobe, R. Nagai, S. Kimura, M. Tomita, P. Froguel, T. Kadowaki, The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nature Medicine. ,vol. 7, pp. 941- 946 ,(2001) , 10.1038/90984
Smita I Negi, Euy‐Myoung Jeong, Irfan Shukrullah, Mihai Raicu, Samuel C Dudley, Jr, Association of low plasma adiponectin with early diastolic dysfunction. Congestive Heart Failure. ,vol. 18, pp. 187- 191 ,(2012) , 10.1111/J.1751-7133.2011.00276.X
Kwang Kon Koh, Michael J. Quon, Seung Hwan Han, Wook-Jin Chung, Yonghee Lee, Eak Kyun Shin, Anti-inflammatory and metabolic effects of candesartan in hypertensive patients. International Journal of Cardiology. ,vol. 108, pp. 96- 100 ,(2006) , 10.1016/J.IJCARD.2005.07.040
Florencia Ziemke, Christos S Mantzoros, None, Adiponectin in insulin resistance: lessons from translational research The American Journal of Clinical Nutrition. ,vol. 91, ,(2010) , 10.3945/AJCN.2009.28449C
Yasushi Amano, Tomohiko Yamaguchi, Kazuki Ohno, Tatsuya Niimi, Masaya Orita, Hitoshi Sakashita, Makoto Takeuchi, Structural basis for telmisartan-mediated partial activation of PPAR gamma Hypertension Research. ,vol. 35, pp. 715- 719 ,(2012) , 10.1038/HR.2012.17
Jianmin Ran, Tsutomu Hirano, Tomoyasu Fukui, Kiyomi Saito, Haruaki Kageyama, Kenta Okada, Mitsuru Adachi, Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance Metabolism-clinical and Experimental. ,vol. 55, pp. 478- 488 ,(2006) , 10.1016/J.METABOL.2005.10.009
Hunjoo Ha, Kyung Hwan Kim, Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C Diabetes Research and Clinical Practice. ,vol. 45, pp. 147- 151 ,(1999) , 10.1016/S0168-8227(99)00044-3